EY Survey

The global consultancy firm EY (formerly known as Ernst & Young) has been commissioned by the NPA to investigate the financial position of the independent community pharmacy sector and inform the first annual review of funding in England under the five-year contractual settlement.

The NPA urges its members to participate in this survey and a letter form the NPA Chair has been sent to which you can read here.

The survey will also capture some details of community pharmacy’s response to the Covid-19 crisis. This period has highlighted not only the challenges that pharmacy is dealing with, but also the important role that community pharmacy can play in soaking up pressure that would otherwise be put on other parts of the health system.


EY Data request – impacts of current funding on community pharmacy

                           Survey deadline: Sunday 14th June


                           Survey link:

Click here to download

The survey should take between 1-2 hours to complete.

Please return completed survey forms to: EYsurvey@npa.co.uk


                        Watch our helpful video:






NPA Support

You may find it helpful to collate the following information before attempting to complete this survey.

Please note: the survey should be completed within the Excel spreadsheet you download.


Identifying Information Tab
  • Contract F Code (found on your FP34 Schedule of Payment from the NHSBSA)
  • GPhC Number
  • NPA Member Number


Segmentation Data Tab
  • Staffing Information (top line – number of FTE)
  • NHS Services Information (List of Local Enhanced Services provided)
  • Private Services Information (List of services provided and total revenue for last financial year)
  • PMR Summary Dispensing Data (if possible)


Financial Data Tab
  • For Financial year 2018-19
  • Management accounts
  • Company YE Accounts
  • FP34 Schedule of Payments from NHSBSA(PPA/PPD statements)
  • Local Authority Payments
  • VAT calculation information
  • Payroll information


Financial Data (2016-18) Tab
  • Management Accounts from 2016-2018


COVID Impact Tab
  • Reports you may have made of products not available at Drug Tariff price
  • Wholesaler Summary Statements


We thank you in advance for your participation in this vital piece of work.